REGN potentially coming into $460 range again.
R/R heavy in favor going long if it falls to this level.
Would keep watch.
Recent phase 3 results re:COVID19
Likely to dip to the 18's before breaking the downward trend (green line).
Two levels of horizontal resistance (yellow lines) and two points of trendline resistance (red lines).
Weekly PT:
Max= $28
Realistic PT = $25
Risk: low 18's
ACCD (Accolade Inc.) - Healthcare Technology
This one just came up on my feed. Shame, buying on Thursday was obvious.
FA: Fiscal report on 1/7 is pretty juicy. 30% increase since last quarter.
Analyst/Activists:
-Purchased by ARK on 1/7/21
-MS upgrade to overweight on 1/8/21 (Healthcare is trending upwards lately which is double benefit)
-Most analyst PT in the...
I've been reading through their studies to see what they're working on and what their proprietary info is being used for and it's actually impressive. Best part is that several of these studies are big on the public conscience, when one of these pops, I can easily see interest in this company peaking real quick.
Partnerships with several major companies: BNTX,...
